These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2545892)

  • 1. mRNA expression of transforming growth factor alpha in human breast carcinomas and its activity in effusions of breast cancer patients.
    Ciardiello F; Kim N; Liscia DS; Bianco C; Lidereau R; Merlo G; Callahan R; Greiner J; Szpak C; Kidwell W
    J Natl Cancer Inst; 1989 Aug; 81(15):1165-71. PubMed ID: 2545892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
    Arteaga CL; Hanauske AR; Clark GM; Osborne CK; Hazarika P; Pardue RL; Tio F; Von Hoff DD
    Cancer Res; 1988 Sep; 48(17):5023-8. PubMed ID: 3165707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of transforming growth factor activity in effusions from cancer patients.
    Hanauske AR; Arteaga CL; Clark GM; Buchok J; Marshall M; Hazarika P; Pardue RL; Von Hoff DD
    Cancer; 1988 May; 61(9):1832-7. PubMed ID: 3162700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transforming growth factor alpha (TGF alpha) in breast cancer.
    Ciardiello F; Kim N; McGeady ML; Liscia DS; Saeki T; Bianco C; Salomon DS
    Ann Oncol; 1991 Mar; 2(3):169-82. PubMed ID: 2043488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth promoting effect of transforming growth factor-alpha in human breast cancer cell lines.
    Kuranami M; Yamaguchi K; Asanuma F; Suzuki M; Abe K
    Jpn J Clin Oncol; 1989 Dec; 19(4):360-6. PubMed ID: 2607638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcripts for transforming growth factors in human breast cancer: clinical correlates.
    Barrett-Lee P; Travers M; Luqmani Y; Coombes RC
    Br J Cancer; 1990 Apr; 61(4):612-7. PubMed ID: 2331446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor alpha in normal human adult kidney and enhanced expression of transforming growth factors alpha and beta 1 in renal cell carcinoma.
    Gomella LG; Sargent ER; Wade TP; Anglard P; Linehan WM; Kasid A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6972-5. PubMed ID: 2582439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
    Pilichowska M; Kimura N; Fujiwara H; Nagura H
    Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.
    Bates SE; Davidson NE; Valverius EM; Freter CE; Dickson RB; Tam JP; Kudlow JE; Lippman ME; Salomon DS
    Mol Endocrinol; 1988 Jun; 2(6):543-55. PubMed ID: 3047554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-alpha activity in effusions: comparison of radioimmunoassay and radioreceptorassay.
    Kamiya Y; Ohmura E; Murakami H; Shizume K; Tsushima T; Demura H; Sakuma N
    Life Sci; 1993; 52(16):1381-6. PubMed ID: 8464337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of transforming growth factors in human breast cancer.
    Murray PA; Barrett-Lee P; Travers M; Luqmani Y; Powles T; Coombes RC
    Br J Cancer; 1993 Jun; 67(6):1408-12. PubMed ID: 8390290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.
    Dalal BI; Keown PA; Greenberg AH
    Am J Pathol; 1993 Aug; 143(2):381-9. PubMed ID: 8393616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factors in human breast cancer.
    Salomon DS; Ciardiello F; Valverius E; Saeki T; Kim N
    Biomed Pharmacother; 1989; 43(9):661-7. PubMed ID: 2624883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
    Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
    Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.
    Bock AJ; Nymoen DA; Brenne K; Kærn J; Davidson B
    Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
    Nagata N; Yasutomo Y; Kugai N; Matsuura Y; Akatsu T; Sugiyama K; Kinoshita T; Takatani O; Mamiya Y; Yamaguchi K
    Jpn J Clin Oncol; 1989 Dec; 19(4):353-9. PubMed ID: 2558242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of transforming growth factor alpha and transforming growth factor beta messenger ribonucleic acid abundance in T-47D, human breast cancer cells.
    Murphy LC; Dotzlaw H
    Mol Endocrinol; 1989 Apr; 3(4):611-7. PubMed ID: 2524651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of transforming growth factor beta 1 mRNA expression in breast carcinomas by in situ hybridization.
    Walker RA; Gallacher B
    J Pathol; 1995 Oct; 177(2):123-7. PubMed ID: 7490677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.